- 01A higher NAD+ number is not a health benefit
NR reliably raises NAD+ in the blood, and that lab result is what most marketing leans on. Trials that looked for something you would notice, like better blood sugar, fat loss, energy or slower aging, mostly found nothing, and muscle NAD+ often did not rise even when blood NAD+ did. Treat the blood number as proof of absorption, not proof of benefit.
Nicotinamide riboside (NR) is a form of vitamin B3 that your cells convert into NAD+ (nicotinamide adenine dinucleotide), a helper molecule needed to turn food into energy and to repair DNA. Trials that measured it have consistently found NR raises NAD+ in the blood, by half or more within two weeks at 300 mg a day and above in the largest dose-finding trial 36. What nobody has shown yet is that the extra NAD+ makes people healthier, fitter or slower to age. The best clinical result so far is a modest gain in walking distance in one 90-person trial 7, and the most careful review of the human research concludes the field tends to oversell its findings 6.
What is nicotinamide riboside?
NR belongs to the vitamin B3 family, and a crystal form called NIAGEN is generally recognized as safe (GRAS) for use in foods 3. For the basics, what it is and what it does in your body has its own page, and this guide covers the evidence, whether NR raises NAD+, NMN vs NR, how much studies use, when and how to take it, side effects and interactions.
Researchers became interested in NR because mouse studies found it raised NAD+ in the liver more efficiently than the older forms of B3 1. NAD+ is used by hundreds of enzymes, including the sirtuins (proteins tied to the cell's stress responses) and the enzymes that repair damaged DNA, which is why it became the centre of a longevity story. The story runs from mice to marketing faster than the human evidence does.
How a capsule of NR becomes NAD+
What NR is good for: the evidence, graded
Each use below carries a grade. Strong means several good randomized trials or a meta-analysis (a study that pools many trials) agree. Moderate means several randomized trials, mostly positive but small or short. Limited means few or small trials, or mixed results. Early means lab, animal or a single pilot study only. Not supported means good trials found no benefit. Our guide how supplements are judged explains why a lab change is weaker evidence than an outcome you can feel or a doctor can measure.
| Use | What the research found | Evidence | Source |
|---|---|---|---|
| Raising NAD+ in the blood | Dose-dependent rises of 22% to 142% over 8 weeks; 60% higher in blood immune cells over 6 weeks; 100% higher after a 9-day dose ramp | Strong | 234 |
| Walking in peripheral artery disease (narrowed leg arteries) | In 90 people over 6 months, 6-minute walk distance changed by +7.0 m on NR vs -10.6 m on placebo; the authors call for a larger trial | Limited | 7 |
| Blood pressure and artery stiffness | Systolic pressure fell 3.9 mmHg on NR in 24 healthy older adults, a trend that did not survive statistical correction | Limited | 4 |
| Low-grade inflammation | Several small trials saw lower inflammatory markers in blood or immune cells; the review calls it the one 'somewhat reproducible' effect | Limited | 6 |
| Insulin sensitivity and blood sugar | 2,000 mg a day for 12 weeks in 40 obese, insulin-resistant men: no improvement | Not supported | 5 |
| Weight, body fat and metabolic rate | No change in body composition, resting energy use or fat burning in the same trial | Not supported | 5 |
| Parkinson's disease (brain energy) | 30 newly diagnosed people, 1,000 mg for 30 days: brain NAD+ rose and inflammatory markers fell in a safety trial | Early | 8 |
| Slowing aging or extending life | Lifespan effects come from animal work; no human trial has measured aging outcomes | Early | 6 |
Does NR raise NAD+ levels?
Yes, and this is the most consistent finding in the NR literature. In the first human pharmacokinetic study, single doses of 100, 300 and 1,000 mg produced dose-dependent rises in blood NAD+ and related molecules, and one volunteer's blood NAD+ rose 2.7-fold after a single dose 1. In an open-label study of 8 healthy volunteers who stepped up to 1,000 mg twice a day, whole-blood NAD+ doubled 2. In the largest dose-finding trial, 8 weeks of 100, 300 or 1,000 mg a day raised whole-blood NAD+ by 22%, 51% and 142%, the rise showed up within 2 weeks, and it held as long as people kept taking NR 3.
The catch is where NAD+ was measured. Most trials measured blood, and in a 6-week crossover trial of healthy adults aged 55 to 79, NAD+ in blood immune cells (PBMCs, peripheral blood mononuclear cells) rose about 60% compared with placebo 4. When trials took muscle samples, the picture changed: the 2023 review lists several in which muscle NAD+ did not move even though by-products of NR rose 6. A higher number in blood is a sign NR was absorbed. It does not show that your heart, muscle or brain cells are running any differently.
NAD+ and aging: what the blood numbers do and don't tell you
The sales pitch for NR rests on two ideas: NAD+ falls as we age, and topping it up slows the decline. The first idea is shakier in people than in mice. A 2026 review notes that recent large-scale human data indicate whole-blood NAD+ does not decline with healthy aging itself 11. Some tissues may run lower in older or sick people, but a blood test cannot show that, and there is no standard clinical test for NAD+ at all.
Collectively, oral nicotinamide riboside supplementation has displayed few clinically relevant effects, and there is an unfortunate tendency in the literature to exaggerate the importance and robustness of reported effects.Damgaard and Treebak, reviewing all 25 published human NR studies, Science Advances, 2023 6
That review, written by researchers who run NR trials themselves, is the fairest single summary of where things stand. It is why every health use on this page sits at Limited or below, however good the NAD+ numbers look.
Blood pressure and arteries
In the 2018 crossover trial, 24 healthy adults (average age 65) took 500 mg of NR twice a day for 6 weeks and a placebo for 6 weeks. Systolic blood pressure averaged 3.9 mmHg lower and diastolic 2.0 mmHg lower on NR, but neither result stayed statistically significant after correcting for the many outcomes tested 4. The authors flagged blood pressure and artery stiffness as the most promising questions for bigger trials, especially in people whose systolic pressure already sits between 120 and 139 mmHg 4. That is a hypothesis, and NR is not a treatment for high blood pressure.
Walking distance with poor leg circulation
Peripheral artery disease (PAD) is narrowing of the arteries to the legs, which makes walking painful. The NICE trial gave 90 people with PAD either 1,000 mg of NR a day, NR plus 125 mg of resveratrol, or placebo for 6 months. Six-minute walk distance improved by 7.0 m on NR and fell by 10.6 m on placebo, a difference of about 17.6 m, and the effect was larger in people who took most of their pills 7. Adding resveratrol gave no extra benefit and more diarrhea: 54.6% on the combination vs 39.3% on NR alone and 27.6% on placebo 7. The same paper notes that in a trial of 30 people with heart failure, 2,000 mg a day raised blood NAD+ but did not change 6-minute walk distance 7. PAD is diagnosed and treated by a clinician, and NR is not a substitute for that care.
Blood sugar, weight and metabolism
Mouse studies suggested NR might improve insulin sensitivity and fatty liver. The human test was a 12-week randomized trial in 40 obese, insulin-resistant men aged 40 to 70, taking 1,000 mg twice a day. Using the gold-standard clamp test, insulin sensitivity did not improve, and neither did glucose handling, resting energy use, fat burning or body composition. Safety blood tests stayed normal 5. If you are watching your blood sugar, our blood sugar guide explains the numbers, and the HOMA-IR calculator turns a fasting glucose and insulin into an insulin-resistance score. Prediabetes is diagnosed and managed with a clinician; NR is not a treatment for it.
Brain and Parkinson's disease
The NADPARK trial gave 30 people newly diagnosed with Parkinson's disease, and not yet on treatment, 1,000 mg of NR or placebo for 30 days. NR was well tolerated, raised brain NAD+ by a variable amount on brain scans, and lowered inflammatory markers in blood and spinal fluid; people whose brain NAD+ rose showed mild clinical improvement 8. This was a phase 1 safety study, so it grades Early, and it is not a reason for anyone with Parkinson's disease to change their treatment.
NMN vs nicotinamide riboside: which is better?
NMN (nicotinamide mononucleotide) is the molecule NR becomes once a cell adds a phosphate to it, so the two are one step apart on the same route to NAD+ 6. NMN's best-known human result is a 10-week trial in postmenopausal women with prediabetes who were overweight or obese: insulin sensitivity in muscle improved on NMN and not on placebo 10. NR has more published human trials, but its own metabolic trial in obese men was negative 5. No trial has compared the two head to head on an outcome that matters to health, so neither can be called better.
NR vs NMN: same destination, one step apart
NR is also often compared with niacin and niacinamide. Niacin (nicotinic acid) in large amounts is known for causing flushing, and in the 8-week trial of NR there were no reports of flushing at any dose 3. Niacinamide (nicotinamide) is cheaper and also feeds NAD+, but in mice NR raised liver NAD+ with different and more favorable kinetics than either older form 1. Whether that difference matters in people has not been tested on health outcomes.
How much NR do studies use?
These are the amounts trials gave, listed as research history and not as a dose for you. There is no Recommended Dietary Allowance for NR and no official upper limit; the authors of the 8-week dose-finding trial wrote that their data support developing one 3.
| Use studied | Amount per day | Form and schedule | Length | Source |
|---|---|---|---|---|
| Blood NAD+ dose finding | 100, 300 or 1,000 mg | NR chloride, once daily | 8 weeks | 3 |
| Blood pressure, NAD+ in older adults | 1,000 mg | 500 mg twice a day | 6 weeks | 4 |
| Walking in PAD | 1,000 mg | Two 250 mg pills twice a day | 6 months | 7 |
| Insulin sensitivity in obese men | 2,000 mg | 1,000 mg twice a day | 12 weeks | 5 |
| Parkinson's disease | 1,000 mg | Daily | 30 days | 8 |
| Pharmacokinetics | 250 mg rising to 2,000 mg | Stepped up to 1,000 mg twice a day | 9 days | 2 |
The highest sustained amount tested in a placebo-controlled trial, 2,000 mg a day for 12 weeks, caused no serious adverse events and left safety blood tests normal 5. Nothing tells us what years of daily use do, because no trial has run that long.
When and how to take NR
How NR was taken in trials
How long does NR take to work? Blood NAD+ rises within 2 weeks 3. The trials looking for a health effect ran from 30 days to 6 months 78, and most found little or nothing you would feel. If you are hoping to notice more energy, the honest expectation is that you probably will not, and there is no test that can tell you NR is working. Can you take NR every day? Trials gave it daily, and NAD+ stayed up for as long as people kept taking it 3. No trial has studied cycling it on and off.
Nicotinamide riboside side effects
In the 8-week trial of 140 adults, side effects were no more common on any dose of NR than on placebo 3. In the 2018 crossover trial, the complaints reported while on NR were one case each of nausea, skin rash, flushing, leg cramps and increased bruising, against four headaches, two episodes of flushing and one rash on placebo 4. In the PAD trial, diarrhea was reported by 39.3% on NR and 27.6% on placebo over 6 months 7.
| Usually mild | Needs prompt care |
|---|---|
| Nausea or an upset stomach | Hives with swelling of the lips, face or tongue, or trouble breathing: emergency care |
| Loose stools | Unusual bruising or bleeding that does not stop: stop the supplement and call your clinician the same day |
| Leg cramps | New or worsening symptoms of a cancer you are being treated for: tell your oncologist |
| Mild flushing (reported no more often than on placebo) | Any severe or unexplained reaction after starting: stop the supplement and get it checked |
Who should avoid NR or ask first
- Pregnancy and breastfeeding: no trials have tested NR in pregnant or breastfeeding women, so safety is unknown. The product label says to consult a healthcare professional first.
- Children: the label says children under 12 should check with a healthcare professional; trials enrolled adults.
- Cancer, now or in the past: in a mouse model of triple-negative breast cancer, NR increased cancer prevalence and spread to the brain 9. This is an animal study, graded Early, but it is the reason to talk to your oncologist first.
- Kidney or liver disease: most trials enrolled healthy or mildly overweight adults, so there is little safety data. Ask the clinician who manages your condition.
- Upcoming surgery: NR has no known effect on clotting, though one person in a small trial reported more bruising 4. Tell your surgical team about every supplement you take.
- Taking regular medicines: interactions have barely been studied, which is not proof there are none.
Nicotinamide riboside interactions
No study has found a clinically important drug interaction with NR, and very few have looked. The table lists the combinations worth raising with a pharmacist, with the reason for each.
| Medicine or situation | What can happen | Why | What to do |
|---|---|---|---|
| Cancer treatment (chemotherapy, targeted drugs, immunotherapy) | Unknown in people; NR fed tumor spread in one mouse study | Cancer cells also use NAD+ to grow 9 | Talk to your oncologist before starting |
| Blood pressure medicines | Possibly a small extra drop in blood pressure | NR showed a non-significant 3.9 mmHg fall in one small trial 4 | Ask your prescriber; note any dizziness on standing |
| Niacin, B-complex or multivitamins with B3 | Doubling up on the B3 family | All feed the same NAD+ pathway | Count total B3 from all products with your pharmacist |
| Diabetes medicines | No added glucose lowering seen | NR did not change insulin sensitivity in a clamp study 5 | Low concern, but tell your prescriber about every supplement |
| Other regular medicines | Not studied | Few interaction studies exist for NR | Ask your pharmacist to check your list |
Supplements to pair or keep apart
| Supplement | Together or apart | Why |
|---|---|---|
| Resveratrol | Together is fine; no added benefit shown | Often sold as a sirtuin pairing, but adding 125 mg of resveratrol to NR gave no extra walking benefit in PAD and more diarrhea 7 |
| B-complex or multivitamin | Together, but count the B3 | Both often contain niacin or niacinamide, which feed the same pathway |
| CoQ10 | Together is fine | Both work in the energy-making machinery of cells; no trial has tested the pair |
| Magnesium | Together is fine | Magnesium helps many energy enzymes; no known interaction with NR |
Blood tests worth knowing about
No routine blood test tracks NR. NAD+ itself is measured only in research labs, so a standard panel cannot show whether NR is working. The tests below are the ones trials used as safety checks or where NR has been studied. Ask your clinician whether any of them make sense for you; they are not a monitoring plan for NR.
| Marker | Why it matters with NR | When it is usually checked |
|---|---|---|
| Homocysteine | Clearing extra B3 uses up methyl groups, which in theory could raise it; NR did not disturb one-carbon metabolism over 8 weeks 3 | When a clinician is assessing heart or B-vitamin status |
| LDL cholesterol | NR did not raise LDL in the 8-week trial 3 | Routine lipid panel |
| hs-CRP | Low-grade inflammation is the one area with a repeated, small signal 6 | Heart risk assessment |
| Fasting glucose and HOMA-IR | Insulin resistance did not improve in a trial that used 2,000 mg a day 5 | Blood sugar screening |
| ALT | A liver safety check; safety blood tests stayed normal in trials 5 | Routine metabolic panel |
| Platelet count | Relevant if you bruise easily; one person reported more bruising on NR in a small trial 4 | Complete blood count |
If fitness and stamina are why you are curious about NR, a direct measure tells you more than any blood test: the VO2 max calculator estimates aerobic fitness, which exercise training is known to change. Our guide to inflammation markers explains what hs-CRP can and cannot tell you.
NR in the LifeFrom pouch
| In the LifeFrom pouch | |
|---|---|
| Product | NR |
| What one serving holds | Nicotinamide Riboside Chloride, 500 mg (Daily Value not established) |
| Form | 1 capsule; vegan capsule (purple carrot veg capsule) |
| How it is packed | One serving in each of your 30 daily pouches, with up to 8 supplements per pouch |
| Price | $27.00 a month, plus the fixed $28.50 a month packing, handling and US delivery line for the whole pouch, not per supplement. Prices as of November 2026; the shop shows the current price. |
| Curated packs that include it | None |
One capsule holds 500 mg of NR chloride, between the 300 mg and 1,000 mg arms of the 8-week dose-finding trial 3 and half the 1,000 mg used in most outcome trials. NR is not in any curated pack, so it only goes in a pouch you build yourself. You can see the shop and its packs.
This guide is general education, not medical advice. Supplements are not FDA-approved for safety or effectiveness, and NR's long-term effects in people are unknown. The clinician who knows your history and your medicines is the right person to decide whether NR makes sense for you; see our medical disclaimer.
Citations
- Trammell SAJ, Schmidt MS, Weidemann BJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun. 2016;7:12948.
- Airhart SE, Shireman LM, Risler LJ, et al. An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers. PLoS One. 2017;12(12):e0186459.
- Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Sci Rep. 2019;9:9772.
- Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9:1286.
- Dollerup OL, Christensen B, Svart M, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. Am J Clin Nutr. 2018;108(2):343-353.
- Damgaard MV, Treebak JT. What is really known about the effects of nicotinamide riboside supplementation in humans. Sci Adv. 2023;9(29):eadi4862.
- McDermott MM, Martens CR, Domanchuk KJ, et al. Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial. Nat Commun. 2024;15:5046.
- Brakedal B, Dölle C, Riemer F, et al. The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. Cell Metab. 2022;34(3):396-407.
- Maric T, Bazhin A, Khodakivskyi P, et al. A bioluminescent-based probe for in vivo non-invasive monitoring of nicotinamide riboside uptake reveals a link between metastasis and NAD+ metabolism. Biosens Bioelectron. 2023;220:114826.
- Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229.
- Alangari A, Arif J, Al Qureshah F, Alkhodairy F. Narrative review of intravenous NAD+ and NAD+ precursors in wellness and translational medicine. Front Aging. 2026.
Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.






